Design and Development of Anti-Ulcer Drug Derivatives for Analytical Studies

ABSTRACTBased on current research in medicinal chemistry, specifically regarding the design anddevelopment of anti-ulcer derivatives, an abstract for this topic typically focuses onsynthesizing new molecules (such as benzimidazole or isoxazole hybrids) to improve efficacywhile reducing side effects like GI toxicity. Below is a structured abstract following standardacademic conventions for this field: Peptic ulcers remain a significant global health concern,characterized by mucosal erosions in the gastrointestinal tract. While conventional therapieslike Proton Pump Inhibitors (PPIs) and H_2 receptor antagonists are effective, they are oftenassociated with side effects, drug interactions, and potential relapses. Furthermore, the chronicuse of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) is a leading cause of gastric injury,necessitating the development of "gastro-sparing" or hybrid anti-inflammatory agents.